Companies

Evocutis

Overview

Evocutis is the new name for Syntopix following its purchase of Leeds Skin in May 2011. It is involved in developing treatments for antibiotic resistance and diseases of the skin. Syntopix was spun-out of Leeds University in 2003 with the backing of IP Group. Syntopix joined Aim on 23 March 2006, when it raised 4m (3.3m net) at 177p a share.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at AIMMicro.com. Subscribe to AIM Micro RSS Feeds